There is no general agreement on the effect of inhalation anesthetics on hypoxic pulmonary vasoconstriction (HPV). We have examined the effect of sevoflurane upon the pulmonary vascular response to a left lower lobe (LLL) hypoxia in dogs by continuously measuring the fractional distribution to the LLL of total pulmonary blood flow (QLLL/QT) employing an ultrasonic transit time rheometer with flow probes attached to the LLL artery and the main pulmonary artery.
Toshiyuki OKUTOMI and Kazuyuki IKEDA There is no general agreement on the effect of inhalation anesthetics on hypoxic pulmonary vasoconstriction (HPV). We have examined the effect of sevoflurane upon the pulmonary vascular response to a left lower lobe (LLL) hypoxia in dogs by continuously measuring the fractional distribution to the LLL of total pulmonary blood flow (QLLL/QT) employing an ultrasonic transit time rheometer with flow probes attached to the LLL artery and the main pulmonary artery.
During regional hypoxia without sevoflurane, blood flow distribution to the LLL as a mean was 48 .2% of that determined under hyperoxic conditions. When sevoflurane was administered at concentrations of 2% and 4%, the LLL blood flow distributions during hypoxia were as a mean 40.2% and 47.0%, respectively, of the values obtained during the first hyperoxic periods. No change occurred in the pulmonary vascular resistance of the LLL(PVRLLL) and the shunt ratio(Qs/Qt) between the concentrations used.
Thus there was no significant effect of sevoflurane upon HPV whatever concentration used. (Key words: dog, hypoxic pulmonary vasoconstriction (HPV), pulmonary circulation, sevoflurane, ultrasonic doppler rheometer) (Okutomi T, Ikeda K: Sevoflurane has no inhibitory effect on hypoxic pulmonary vasoconstriction (HPV) in dogs. J Anesth 4: 123-130, 1990) .Hypoxic pulmonary vasoconstriction (HPV) is a mechanism which counteracts arterial hypoxemia by diversion of pulmonary blood flow from poorly to more properly oxygenated areas of the lungs". Although many reports have appeared in the last few years on the effect of inhalation anesthetics on HPV employing either isolated lungs 2 -5 or lungs in situ 6 ,7 , none of them have dealt with sevoflurane.
In a previous study in mongrel dogs, we rendered the left lower lobe (LLL) atelectatic and observed the pulmonary vascular reDepartment of Anesthesiology, Hamamatsu University School of Medicine, Hamamatsu City, Shizuoka, Japansistance and shunt ratio while administering sevoflurane via the rest lung. We found no change caused by sevoflurane and assumed that at clinically assigned doses, sevoflurane would not influence HPV8. In the present study, we wanted to investigate, more indepth, the effect of sevoflurane on HPV by measuring the percentage distribution of pulmonary blood flow to the left lower lobe using a pulse doppler rheometer.
Materials and Methods

a) Anesthesia and Operation
Nine female mongrel dogs (7.6 ± 2.2 kg) were anesthetized with 30 mg-kg " ! of sodium pentobarbital (supplemented with 25-50 mg when blood pressure or heart rate increased) and 0.2 mg-kg"! of pancuronium (supplemented with 0.5 mg when spontaneous respiration appeared). A tube of 9.5 mm inner diameter was inserted into the trachea and the lungs were ventilated with 100% oxygen. A 20G plastic needle was put into the femoral artery to be used for sampling arterial blood and monitoring of arterial pressure. A 7 Fr Swan-Ganz catheter was inserted into the internal jugular vein and used for sampling mixed venous blood and pulmonary arterial pressure monitoring. A 18G central venous catheter was also inserted into the internal jugular vein (same side) for measurement of the right atrial pressure. Then, a leftsided thoracotomy was performed at the fourth intercostal space and the left auriue was cannulated through the left atriclm for measurement of the left atrial pressure. Pressures were recorded with a Hawlett Packard monitoring system (HP78342A Monitor with HP1290A quartz pressure transducer) by adjusting the reading at the mid-cardiac level to zero by in vitro calibration. Blood flow was determined by means of an ultrasonic transit time rheometer (Transonic T101, AD-VANCE CO., LTD.), which was attached to the main pulmonary artery (mPA), and to the left lower lobe (LLL) artery employing flow probes of an internal diameter of 12 and 3 mm, respectively. Blood flow in the mPA was regarded as equal to the cardiac output (QT), and the blood flow distribution to the LLL was expressed as a fraction of cardiac output (QLLL/QT). A 14 Fr tube was inserted into the bronchus of the LLL and fixed there with the central end of the bronchus completely ligated. The residual lung (RL) was ventilated (Harvard NSH-34RH) with pure oxygen for the whole experimental period with 5 cmH.O PEEP. The LLL was not ventilated with pure oxygen as was the residual lung. 2 l-min"! flow (Igarashi precision membrane flow meter F-1) with 100% oxygen or anoxic mixed gas (95%N2+5%C02) was applied to LLL under 5 cmH 20 CPAP with a water seal. A change in the gas composition of the LLL was preceded by 20 ventilations (tidal volume is about 200 ml) to provide a homogeneous gas mixing prior to each sequence. The LLL end-tidal concentration of sevoflurane was continuously measured. The RL end-tidal concentration of sevoflurane was intermittently measured. RL ventilation was started under conditions of 300 ml.kg-1·min-1, and was controlled later so that end-tidal CO 2(DATEX CD300 CO 2 ANALIZER) was kept between 35 mmHg and 45 mmHg.
Physiologic saline was continuously infused at a rate of 50-100 ml-hr :". Sodium bicarbonate was infused i.v, to correct any metabolic acidosis. Blood temperature was monitored and maintained at 37 ± 2°C with the use of blankets and table lamps.
b) Experimental Protocol
Prior to the investigational period, LLL was exposed to three hypoxic challenges, each lasting 15 min interrupted by 15 min of 100% oxygen administration to achieve the maximum HPV.
After that, the effects on LLL hemodynamics of sevoflurane randomly administered at concentrations of 0, 2 or 4% were studied. Each experiment consisted of three sequences, a control period of LLL O 2 administration lasting one hour, a period of LLL anoxic mixed gas administration and a second period of LLL O 2 administration, each lasting 30 min. Sevoflurane was given throughout the entire period of the experiment. After~ach sequence, blood flow in the mPA and in the LLL artery were determined as well as heart rate, systemic blood pressure, pulmonary artery pressure, central venous pressure and left atrial pressure.
A sevoflurane vaporizer (ACOMA CO.) was used. The concentration of sevoflurane was measured with an inhalation anesthetic gas analyzer (RIKENEIKL RI-507M) calibrated by means of gas chromatography (SHIMAZU GC-9A). In order to minimize the possibility of fluctuations in the general circulatory condition, sevoflurane was given only to the LLL. Arterial and mixed venous oxygen and carbon-dioxide tensions, and pH, were measured with established techniques (ABL-2 analyzer, Radiometer Co). Hemoglobin concentration and oxygen saturation of blood were measured by spectrophotometry (0 SM-2, Radiometer Co).
The electrodes were calibrated with known gases and buffer solutions before each determination. The shunt ratio was calculated by Hill's equation'', To confirm the reproducibility of the results, three sequences in the 4th experiment were performed in 6 of the 9 dogs. Sevofl.urane was administered in the same concentration as in the first experiment. c) Statistics and Calculations Analysis of variance (ANOVA) was employed in a statistical comparison between the concentration of sevofl.urane, while paired t-test was used in statistical comparison between each phase, and between the first and fourth administrations at the same concentration; the differences being labeled as significant at P < 0.05 invariably.
Results
No significant difference was observed in pH, Paco 2, QT, heart rate, mean arterial pressure, right atrial pressure, left atrial pressure, systemic vascular resistance, or pulmonary vascular resistance of the residual lung; between each of the 1st 02-administration phase, anoxic gas administration phase, and the 2nd 02-administration phase, or between each concentration of sevofl.urane ( 
Discussion
It is of interest that LLL perfusion decreased and LLL pulmonary vascular resistance (PVRL LL) increased during exposure of the LLL to the anoxic gas mixture. Furthermore, since no significant difference was observed in these changes between concentrations of administered sevoflurane (0%, 2%, and 4%), it is considered that administration of sevoflurane does not influence these changes in the experiments.
In according to previous animal studies, a fundamental property of inhalational anesthetics is to decrease HPV. However, in intact animal preparations some biologic or physiologic property seems to remove or greatly lessen the inhibitory effect of anesthetic drugs' on HPV. Sykes et a1. 10 reported the pulmonary vasoconstrictor response to alveolar hypoxia was preserved during the administration of halothane to in vivo-intact dogs. Saidman et al, 11 reported isoflurane did not inhibit hypoxic pulmonary vasoconstriction in vivo-intact dogs. Hypoxic pulmonary vasoconstriction during the administration of other inhalational anesthetics was [dyne-em-sec -5)
Abbreviations: QT = cardiac output, blood flow of main pulmonary artery; HR = heart rate; MAP = mean arterial pressure; LAP = left atrial pressure; RAP = right atrial pressure; SVR not studied with the same model, so sevoflurane and other inhalational anesthetics were not compared. However, the effect of sevoflurane on HPV may be subtle and it has a number of desirable properties which permit a high concentration of oxygen during anesthesia and a rapid emergence from anesthesia, so the inhalational anesthetic is a useful for the thoracic surgery which requires one-lung ventilation.
In our experiment we repeated, intermittently, hypoxic challenges to the LLL. Chen et al. 12 concluded that in the absence of surgical trauma the initial response to hypoxia was maximal and was not potentiated by repeated hypoxic stimulation. On the contrary, Unger et al. 13 and Marshall-" reported that potentiation by repeated challenge seemed to be more pronounced, to some extent, the more extensive the surgical preparation of the lungs had been. So hypoxic challenges for the LLL were needed.
In the present study, the LLL was not ventilated and was kept under CPAP. However, the LLL end-tidal sevoflurane concentration was insignificantly changed through hypoxic gas challenge in blood gas analysis and hemodynamic dates *P < 0.05 significance between C1 and C2, **P < 0.05 significance between C1 and H, ***P < 0.05 significance between Hand C2 each experiment. One problem for no ventilation is the different end-tidal Peo2-values in two separated parts of the lung or the difference in ventilation mechanics. In other words, LLL Peo 2 will be higher than RL P C02 because the mixed venous/alveolar P CO 2 gradient will be less in LLL than in RL. Regional PVR will increase with an increase in end-tidal P e o 2 and that may increase the response of HPV. But this will not make it impossible to compare HPV responses among different sevoflurane concentrations.
In terms of circulatory stability, it was desirable that the cardiac output was measured directly by attaching the probes to the main pulmonary artery instead of using the thermodilution method with a Swan-Ganz catheter.
An electromagnetic flowmeter has often been used for the measurement of blood flow. However, there have been problems in preparation for experiments with this device; a flow probe must be chosen precisely depending on the diameter of blood vessels to be examined, and measurement values than in the period of anoxic gas administration (Flo2 = 0.0) (***P < 0.05) without sevofiurane and at the concentrations of 2%, while during the period of the 2nd 02-administration (FI02 = 1.0) the pressures remained higher than during the 1st 02-administration (Flo2 = 1.0) (*P < 0.05) at the concentration of 2% and 4%.
could vary depending on the extent to which the vessel is detached from connective tissue surrounding it. Therefore, we used an ultrasonic transit time rheometer for blood flow measurement in this experiment. This type of rheometer enabled us to measure the flow rate directly regardless of the diameter of blood vessel. And it is important whether the measurement is based upon a continuous and stable determination of the transsectional area of the vessels. The flow probe has advantages in that it can correct aberrations in attachment angles by 2 return-samplings and that an adoption of free bracket has resolved the problem of deviation caused by pressure.
In conclusion, we have found that a local administration of sevoflurane has no inhibitory effect on HPV at the clinically assigned dose on the assumption that inhibition of HPV is dependent on the concentration of inhalation anesthetic in alveoli. Taking the results of our previous study on HPV in atelectasis into consideration, we believe that sevoflurane can be used safely even in cases in which HPV plays an important part, such as a lung operation.
